Intriguingly, in the postmortem cortex of AD patients, the remarkable increase in the expression of PSEN1 is linked to reduced methylation both at CpG and non-CpG sites, contributing to the worsening of AD pathological features [68]. This evidence concerns the gene PSEN1 and Alzheimer disease.